Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/19552
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPipilis, A.en
dc.contributor.authorAndrikopoulos, G.en
dc.contributor.authorLekakis, J.en
dc.contributor.authorKalantzi, K.en
dc.contributor.authorKitsiou, A.en
dc.contributor.authorToli, K.en
dc.contributor.authorFloros, D.en
dc.contributor.authorGaita, D.en
dc.contributor.authorKaralis, I.en
dc.contributor.authorDragomanovits, S.en
dc.contributor.authorKalogeropoulos, P.en
dc.contributor.authorSynetos, A.en
dc.contributor.authorKoutsogiannis, N.en
dc.contributor.authorStougiannos, P.en
dc.contributor.authorAntonakoudis, C.en
dc.contributor.authorGoudevenos, J.en
dc.date.accessioned2015-11-24T19:00:32Z-
dc.date.available2015-11-24T19:00:32Z-
dc.identifier.issn1741-8275-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/19552-
dc.rightsDefault Licence-
dc.subjectAdrenergic beta-Antagonists/therapeutic useen
dc.subjectAgeden
dc.subjectAngina Pectoris/epidemiologyen
dc.subjectAngioplasty, Balloon, Coronaryen
dc.subjectAngiotensin II Type 1 Receptor Blockers/therapeutic useen
dc.subjectAngiotensin-Converting Enzyme Inhibitors/therapeutic useen
dc.subjectAnticoagulants/therapeutic useen
dc.subjectDrug Utilizationen
dc.subjectFemaleen
dc.subjectGreece/epidemiologyen
dc.subjectHealth Facilities/*statistics & numerical dataen
dc.subject*Heart Catheterizationen
dc.subjectHeart Failure/epidemiologyen
dc.subjectHeparin/therapeutic useen
dc.subject*Hospitalizationen
dc.subjectHumansen
dc.subjectHydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic useen
dc.subjectMaleen
dc.subjectMyocardial Infarction/epidemiology/*therapyen
dc.subjectMyocardial Reperfusionen
dc.subject*Outcome Assessment (Health Care)en
dc.subjectPlatelet Aggregation Inhibitors/therapeutic useen
dc.subjectRecurrenceen
dc.subjectRegistriesen
dc.subjectShock/epidemiologyen
dc.subjectStroke/epidemiologyen
dc.titleOutcome of patients with acute myocardial infarction admitted in hospitals with or without catheterization laboratory: results from the HELIOS registryen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.primary10.1097/HJR.0b013e32831e954e-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/19188809-
heal.identifier.secondaryhttp://cpr.sagepub.com/content/16/1/85-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate2009-
heal.abstractAIMS: To compare the treatment and outcomes of myocardial infarction patients in hospitals with and without catheterization laboratory. METHODS AND RESULTS: The Hellenic Infarction Observation Study was a countrywide registry of acute myocardial infarction, conducted during 2005-2006. The registry enrolled 1840 patients with myocardial infarction from 31 hospitals with a proportional representation of all types of hospitals and of all geographical areas. Out of these patients, 645 (35%) were admitted in 11 hospitals with and 1195 (65%) in 20 hospitals without catheterization laboratory. Patients admitted in hospitals with catheterization laboratory in comparison with patients admitted in hospitals without were younger (66+/-14 vs. 68+/-13, P<0.004) with less diabetes (27 vs. 33%, P<0.001), but without other baseline differences (female 27 vs. 25%, prior myocardial infarction 20 vs. 17%, Killip class>1 22 vs. 23%). Reperfusion rates for ST-segment elevation myocardial infarction were 67% (43% lytic, 24% primary percutaneous coronary interventions) versus 56% (55% lytic, 1% percutaneous coronary interventions; P<0.01). In-hospital outcomes in hospitals with versus in hospitals without laboratory were: mortality 6.5 versus 8.3% (NS), stroke 2.2 versus 1.1% (NS), major bleeding 1.1 versus 0.6% (NS), and heart failure 11 versus 16% (P<0.01). In multivariate regression analysis, being admitted in a hospital without catheterization laboratory was not an independent predictor of increased in-hospital mortality (odds ratio=1.18, 95% confidence interval: 0.72-1.93, P=0.505). CONCLUSION: Although the majority of acute myocardial infarction patients was admitted in hospitals without catheterization laboratory, these patients do not have a survival disadvantage, provided they are treated with lytic therapy, medical secondary prevention drugs, and eventual revascularization according to current guidelines.en
heal.journalNameEur J Cardiovasc Prev Rehabilen
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
There are no files associated with this item.


This item is licensed under a Creative Commons License Creative Commons